Related Experiment Video
Updated: Jul 20, 2026

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo
Published on: January 7, 2019
Future directions for vaccine-based therapies
1Genitourinary Cancer Immunotherapy Program, Division of Urology, Department of Surgery, Duke University Medical Center, Durham, NC 27710, USA. j.vieweg@duke.edu
Abstract:
During recent years, cancer vaccines have made encouraging progress toward becoming a clinically relevant form of biologic therapy. However, current vaccine approaches have shown only limited success in patients with cancer because of inadequate immune activation. Recent insights into the elements that regulate immune responsiveness have provided new opportunities to enhance the efficacy of cancer vaccines through multiple pathways that involve afferent and efferent arms of the immune system. This article presents a set of emerging strategies that have resulted from our recent efforts to boost tumor-associated antigen-specific immunity and improve patient outcome. These new insights represent important consideration for the design and development of more effective immunotherapies during the next decade.
Insights
Recent advances in cancer vaccines aim to improve immune activation for better patient outcomes. Emerging strategies focus on enhancing tumor-specific immunity for more effective cancer immunotherapies.
Area of Science:
- Immunology
- Oncology
- Biologic Therapy
Background:
- Cancer vaccines show promise but have limited success due to inadequate immune activation.
- Recent discoveries in immune response regulation offer new avenues to improve vaccine efficacy.
Purpose of the Study:
- To present emerging strategies for enhancing cancer vaccine efficacy.
- To boost tumor-associated antigen-specific immunity and improve patient outcomes.
Main Methods:
- Review of recent insights into immune system regulation.
- Exploration of pathways involving afferent and efferent immune responses.
Main Results:
- Identification of novel strategies to enhance anti-tumor immunity.
- Potential for improved patient outcomes through optimized vaccine design.
Conclusions:
- New insights are crucial for developing more effective cancer immunotherapies.
- Future cancer vaccine development should consider these emerging strategies for enhanced immune activation.
Related Concept Videos
Microorganisms in Medicine and Therapeutics
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Tumor Immunotherapy
Vaccines
Vaccinations
Vaccine Production
